SALT LAKE CITY, June 16, 2025 — Lumion, the company building the most comprehensive operating system for career and trade schools, today announced it has raised a total of $10.7 million in seed funding led by TTV capital with recent participation from Tusk Venture Partners. The round also includes prior support from TTV Capital, CreativeCo Capital, Nine Four Ventures, Innovating Capital, and the State of Wyoming.

The funding comes amid a pivotal moment for the U.S. workforce. As the country faces a critical skilled labor shortage, enrollment growth in trade and technical programs is outpacing that of four-year colleges. Lumion is emerging as the infrastructure layer that enables schools to meet that demand, streamlining student acquisition, operations, and outcomes from end to end.

“Trade schools have been stuck managing mission-critical processes across spreadsheets, disconnected CRMs, and legacy student information systems (SISs),” said Joshua Hagani, CEO of Lumion. “We’ve built the ultimate platform to unify the full student experience from lead capture all the way through alumni tracking.”

Originally focused on student financing, Lumion has evolved into an All-in-one SaaS platform enabling trade and technical schools to grow efficiently and serve more students. Over the last year, the company has tripled its revenue, customer base and team, supporting over 100,000 students across 260+ partner schools in more than 29 industries.

The new Lumion Platform includes three major product lines:

• Enrollment: Schools can now generate and manage prospective student leads from their own website, funneling them into a centralized enrollment flow with applications, communication, scheduling and onboarding capabilities.
• Payments: Once a lead is captured and nurtured, students are guided through all available payment options including upfront payment, a lender marketplace, and school-administered payment plans ensuring increased enrollment, retention, and collection. Lumion handles all collections and servicing on behalf of schools.
• Full-Service SIS Capabilities: Lumion provides centralized comprehensive reporting of all student activities and interactions, bringing clarity and insights to school operators.

Lumion brought in Tusk Venture Partners to top off its seed round due to surplus investor demand in late 2024, accelerating market expansion and continuing product innovation.

To date, Lumion has:

• Processed over 140,000 tuition payments
• Enabled 1,690 school administrators
• Delivered an estimated $20 billion in human capital impact
• Grown to a 35-person team headquartered in Salt Lake City

With government policy tailwinds behind workforce development and a broken traditional higher education model, Lumion is the operating system of choice for trade & technical schools.

About Lumion
Lumion is the all-in-one platform for trade and technical schools, streamlining the full student lifecycle from lead generation and tuition payments to enrollment, reporting, and alumni tracking. Headquartered in Salt Lake City, Lumion is building the infrastructure for the future of skilled education. Learn more at joinlumion.com.

SOURCE Lumion

Highlights:

• Over $11 Million Raised: Proceeds were generated through the exercise of existing warrants. Chardan Capital Markets was the exclusive financial advisor in connection with public warrant exercises.
• Update on NASDAQ Compliance: Klotho believes it now exceeds the stockholders’ equity thresholds required to remain in compliance with NASDAQ listing requirements.
• Zero Debt: Klotho has fully extinguished all outstanding debt, resulting in a debt-free balance sheet.

NEW YORK, June 16, 2025 — Klotho Neurosciences, Inc. (NASDAQ: KLTO), a U.S.-based biogenetics company, today announced that over the course of the last ten days, it raised over $11 million in funding through the exercise of existing warrants by investors. The Company believes that it now surpasses Nasdaq’s stockholders’ equity requirement requirements outlined in its Nasdaq compliance plan.

In addition, the Company utilized  $3.1 million of the funds raised to extinguish all outstanding debt, resulting in a debt-free balance sheet.

About Klotho Neurosciences, Inc. 
Klotho Neurosciences, Inc. (NASDAQ: KLTO) is a biogenetics company focused on the development of innovative, disease-modifying cell and gene therapies using an important human protein derived from the Company’s patented form of the “anti-aging” human Klotho gene (s-KL) and its novel promoter and delivery systems to transform and improve the treatment of neurodegenerative and age-related disorders such as ALS, Alzheimer’s, and Parkinson’s disease. The company’s current portfolio consists of its proprietary cell and gene therapy programs using DNA and RNA as therapeutics and genomics-based diagnostic assays. The company is managed by a team of individuals and advisors who are highly experienced in biopharmaceutical product development and commercialization.

For more information, contact:
Investor Contact and Corporate Communications – Jeffrey LeBlanc, CFO
[email protected]

Website: www.klothoneuro.com

Forward-Looking Statements:

This press release contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Without limiting the generality of the foregoing, the forward-looking statements in this press release include descriptions of the Company’s future commercial operations. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, such as the Company’s inability to implement its business plans, identify and realize additional opportunities, or meet or exceed its financial projections and changes in the regulatory or competitive environment in which the Company operates. You should carefully consider the foregoing factors and the other risks and uncertainties described in the documents filed or to be filed by the Company with the U.S. Securities and Exchange Commission (the “SEC”) from time to time, which could cause actual events and results to differ materially from those contained in the forward-looking statements. Copies of these documents are available on the SEC’s website, www.sec.gov. All information provided herein is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law.

SOURCE Klotho Neurosciences, Inc.

Performance Brokerage Services, the leader in dealership buy-sell activity, announces the sale of Palmdale Kia in California from Top-40 dealership group, Nouri/Shaver Automotive Group to Trust Auto Group

IRVINE, Calif., June 16, 2025 — Performance Brokerage Services, North America’s highest volume dealership brokerage firm, is pleased to announce the sale of Palmdale Kia in California from Top-40 dealership group, Nouri/Shaver Automotive Group to Trust Auto Group.

Nouri/Shaver Automotive Group is led by Co-Owners Bob Nouri and Pete Shaver, along with CEO Armina Mgerian. The group operates 16 franchised dealerships in California and Oregon. Nouri/Shaver Automotive Group ranks #40 on the Automotive News Top 150 Dealership Groups based on new-vehicle sales in 2024, generating over $2 billion in revenue, and employing more than 2,000 individuals.

After the sale, Bob Nouri shared, “I’m incredibly thankful for Jason Stopnitzky of Performance Brokerage Services’ pivotal role in selling one of our dealerships, which wasn’t even listed for sale. His integrity, marked by unwavering honesty, transparency, and a steadfast commitment to doing what’s right, set him apart in every interaction. He navigated the process with professionalism and genuine care, making it not only seamless but also a true pleasure. In an industry with many great people, Jason’s exceptional character and principled approach make him a rare gem. It’s an honor to work with someone of such high caliber. Thank you, Jason, for your remarkable impact!”

Over the last 5 years, Performance Brokerage Services has advised on the sale of nearly 400 dealerships, making it the highest volume dealership brokerage firm in North America. Jason Stopnitzky, Co-Founder, and Jesse Stopnitzky, Co-Owner of Performance Brokerage Services were the exclusive sell-side advisors for this transaction.

Jason Stopnitzky commented, “Bob Nouri, Pete Shaver, and Armina Mgerian have my deepest gratitude for their unwavering trust and collaboration. This marks our fifth transaction together. After 27 years in the business, I’ve been a part of hundreds of transactions and have worked alongside many dealers. The team they’ve built sets the gold standard in the industry I’ve dedicated my life to. The way they treat their employees, customers, and OEMs across 16 dealerships sets an incredibly high bar, and it’s amazing how they continue to strive for excellence while managing over 2,000 employees. I feel truly blessed and fortunate to be part of their inner circle. As always, I’m thankful for the chance to serve, and I always give my all for the Nouri/Shaver Automotive Group.”

Jason continued, “I’m also grateful to Edgar Castellanos and Trust Auto Group for their trust and partnership in acquiring Palmdale Kia. It’s been a pleasure to witness how both parties worked together seamlessly throughout the process, and I’m confident that the legacy of Palmdale Kia will continue under Trust Auto Group’s stewardship. The collaboration between both sides was a testament to what can be achieved when great people come together to achieve a common goal.”

Trust Auto Group is a locally owned and operated dealership group with five locations across Costa Mesa, Lancaster, and Palmdale, California. The group represents brands including Honda, Subaru, Kia, and Lotus.

President of Trust Auto Group, Edgar Castellanos commented, “It’s been an absolute pleasure working with Jason Stopnitzky of Performance Brokerage Services, from the initial call to the conclusion of our purchase. Every step of the way, he handled the process with urgency and care. His attention to detail and meticulous oversight of the entire process made the acquisition stress-free. Looking forward to many more years of working with him and his team.”

Nouri/Shaver Automotive Group was represented by Monica Hoenshell of Calvert Law Firm in Oklahoma City, Oklahoma.

Palmdale Kia will be renamed Trust Kia of Palmdale and will remain at its current location at 438 Auto Vista Drive in Palmdale, California.

About Performance Brokerage Services

Performance Brokerage Services, Inc. is North America’s highest volume dealership brokerage firm, specializing in buy-sell activity for automotive, RV, commercial truck, powersports, and equipment dealerships.

With over 30 years of experience, 900 dealerships sold, and a 90% closing rate, the company’s reputation is unmatched and governed by the utmost ethical conduct and integrity.

The company offers a unique approach by providing complimentary estimates of value with no upfront fees or retainer, no reimbursement of costs, and paid a success fee only after the transaction closes.

Headquartered in Irvine, California and supported by 12 regional offices across the United States and Canada, clients benefit from national exposure with local representation.

As trusted and respected experts in the field, the company utilizes an extensive network of industry related attorneys, accountants, hundreds of registered buyers, and longstanding relationships with various vehicle manufacturers.

For more information about the services offered by Performance Brokerage Services, visit https://performancebrokerageservices.com. 

Media Contact: 
Jesse Stopnitzky, Co-Owner
(949) 309-2851
[email protected]

SOURCE Performance Brokerage Services, Inc.

• Pioneering the Future of Surgical Care in Response to Rising Demand

TOKYO, June 15, 2025 — SDP Japan, Inc. (Shibuya-ku, Tokyo; CEO: Kazuhiko Nagayo), announced today that the Company has successfully raised approximately JPY 4.5 billion (equivalent to USD 31 million) through a Series D equity financing round, alongside secondary transaction, debt financing and asset-based funding. The equity round was led by Japan Post Investment and included participation from seven institutional investors.

Background and Future Outlook

Japan’s super-aging society continues to fuel steady growth in the healthcare sector, particularly in the fields of orthopedics and cardiovascular — two core areas of focus for SDP Japan. Surgical procedures in these specialties are increasing at 5–8% per annum, with demand projected to grow through 2050, according to research by Yano Research Institute.

Despite growing need, the surgical care sector faces systemic challenges: surgeons often lack access to adequate infrastructure and support, while patients continue to struggle with finding reliable specialists — often by chance — highlighting persistent disparities in access to information and care.

SDP Japan is redefining the surgical care model by building integrated platforms where physicians can focus purely on their expertise, and patients are guided seamlessly toward optimal treatments. With a unique position at the intersection of patient marketing, facility production, and healthcare operations management, the Company has expanded the footprint of surgery-focused medical institutions — primarily in urban areas — and is now poised to scale its next-generation model nationwide.

This funding round will further strengthen SDP Japan’s growth platform and enable the rollout of advanced surgical care models to underserved regions. The Company is committed to rebuilding medical infrastructure in regional cities through close collaboration with stakeholders across the healthcare ecosystem, aiming to establish a sustainable and equitable healthcare system.

With the agility and execution power of a startup, SDP Japan aspires to be a transformative force in the Japanese healthcare industry.

About SDP Japan

SDP Japan, Inc. is a healthcare startup with a mission to ‘deliver joy and inspiration through advanced surgical care.’ The Company supports the nationwide development of specialty surgical institutions in orthopedics and cardiovascular. SDP Japan offers a wide range of services to its partner medical institutions, including patient acquisition (marketing), supply procurement, real estate and medical equipment sourcing, and administrative support — delivering innovative solutions across the surgical care spectrum.

Since its founding in 2014, SDP Japan has helped produce seven surgery-focused institutions in the Tokyo metropolitan area. In 2024, its supported facilities performed over 3,000 surgeries, bringing the cumulative total to approximately 14,000. Those institutions rank third in Tokyo for both arrhythmia and hip joint replacement surgeries, based on the number of procedures performed (source: Shukan Asahi Mook, “Best Hospitals for Surgery 2024”).

Internationally, outpatient surgical centers are widely adopted in the form of ASCs (Ambulatory Surgical Centers) or HOPDs (Hospital Outpatient Departments), driven by robust patient outcome data. SDP Japan aims to support the establishment of a Japanese version of the ASC platform tailored to Japan’s public insurance system, contributing to the realignment of acute cares.

At the heart of our mission is the desire to deliver life-changing outcomes for patients and their families through the hands of exceptional surgeons.

Message from the CEO, Kazuhiko Nagayo

We are pleased to announce the successful completion of a JPY 4.5 billion funding round. I would like to express my sincere gratitude to our investors and supporters. At SDP Japan, we have relentlessly pursued a healthcare environment where physicians can thrive and patients can access the best possible care. Today, we support more than 3,000 surgeries annually and are committed to expanding this model to regional areas, eliminating disparities across the nation.

People are at the core of our growth. I look forward to working with mission-driven individuals who share our passion and expertise.

List of Series D Investors (in no particular order)

Existing Investors:

• Eight Roads Ventures Japan
• Globis Capital Partners

New Investors:

• Japan Post Investment (Lead Investor)
• T&D Innovation Fund / Spiral Innovation Partners
• Sumitomo Mitsui Trust Bank
• Japan Co-Invest No. 4 Fund / Sumitomo Mitsui Trust Investment
• Toda Corporation

List of Lenders (in no particular order)

• Resona Bank
• Shizuoka Bank
• SBI Shinsei Bank

Comments from New Investors

• Japan Post Investment (Lead Investor): Kei Mizukami, Executive Vice President and CIO

SDP Japan is creating an environment where surgeons can fully focus on their procedures, enabling patients to receive high-quality surgical care efficiently and safely. At the same time, the Company contributes to improving working conditions and career development opportunities for physicians. We view this initiative as one that will raise the overall standard of surgical care in Japan and improve public health outcomes, making it a compelling opportunity for impact investment. We look forward to supporting SDP Japan’s medium- to long-term growth as it partners with medical institutions across the country.

• Sumitomo Mitsui Trust Bank: Kazuya Yoneda, Head of Impact Equity Investment Department

We highly value SDP Japan Inc. as a platform company that provides unique support services for the establishment and operation of surgery-focused hospitals and clinics. Their ability to simultaneously enhance efficiency and improve the quality of medical care is particularly commendable. At our bank, we aim to support initiatives and challenges that address social issues through financial means. Through this investment, we strive to contribute to the improvement of well-being for a broad and inclusive range of people, including future generations.

• T&D Innovation Fund (managed by Spiral Innovation Partners): Kazuhiro Kamata and Yuqing Wei 

We believe that the nationwide expansion of specialized surgical medical institutions supported by SDP Japan will contribute significantly to the advancement of Japan’s healthcare system. The T&D Innovation Fund actively invests in startups in the healthcare, pet care, and insurtech sectors, and we are fully committed to supporting the growth of SDP Japan going forward.

• Japan Co-Invest IV Investment / Sumitomo Mitsui Trust Investment: David Su, Director of Investments

We saw a unique opportunity to align strong investment returns with meaningful social impact by supporting SDP Japan in expanding its network of surgery-specialized medical facilities nationwide. Similar models have been successfully evolved in the U.S. since the 1970s, contributing to reduced healthcare costs and improved access to advanced care. We are excited to back SDP Japan as it builds an innovative medical infrastructure that truly reflects the commitment of physicians and the needs of patients. We look forward to continuing our support beyond the investment itself.

• Toda Corporation: Masato Kudo, General Manager, Innovation Promotion Division

Toda Corporation has invested in SDP Japan with the goal of advancing the medical industry and addressing key social challenges. In response to the growing number of surgeries and structural issues in the healthcare sector, SDP Japan is working to establish next-generation surgical medical facilities. Guided by our vision of being ‘more than just a hospital builder,’ we are excited to collaborate with SDP Japan in building systems that empower physicians to perform at their best and ensure that patients receive the optimal treatment they need.

Join Our Mission

To accelerate the expansion of our partner medical institutions, we are hiring in the following areas:

• Patient marketing (digital and offline)
• Business development (medical supply procurement, physician support, turnaround initiatives)
• On-site operations (including secondments, roles for experienced medical office managers)

Visit our recruitment page for more information (Japanese only):
https://www.sdp-japan.com/recruit/info/

Company Profile

• Company Name: SDP Japan, Inc.
• Headquarters: Shibuya Dogenzaka Tokyu Building 6F, 1-10-8 Dogenzaka, Shibuya-ku, Tokyo
• Founded: January 14, 2014
• Website: https://www.sdp-japan.com/

Contacts

SDP Japan, Inc. – Public Relations
Tel: +81-3-6457-9303
Email: [email protected] 

SOURCE SDP Japan, Inc

MCKINNEY, Texas, June 13, 2025 — Cytracom, a leading provider of Secure Access Service Edge (SASE) and Unified Communications as a Service (UCaaS) solutions for Managed Service Providers (MSPs), today announced the acquisition of Tentacle, a modern platform that helps organizations manage cybersecurity assessments, monitor third-party risk, and operationalize Governance, Risk, and Compliance (GRC) programs.

This acquisition represents a significant advancement in Cytracom’s Security Risk Management (SRM) strategy and further aligns with the company’s mission to empower MSPs to grow beyond traditional IT services and embrace a more strategic advisory role, guiding their clients through the evolving discipline of risk management. With increased scrutiny from regulatory bodies and mounting pressure from cyber insurers, MSPs are being called upon to act as true Risk Advisors, helping clients meet compliance mandates and improve their overall security posture. The integration of Tentacle into the Cytracom platform delivers a robust response to this need, offering structured, repeatable, and collaborative tools that make it easier for MSPs to deliver value-added risk and compliance services.

Cytracom entered the SRM category through the acquisition of Telivy, introducing capabilities that enable MSPs to automate risk assessments, deliver recurring compliance documentation, and drive consultative engagements. Tentacle builds upon this foundation by allowing partners to centralize security program data, collaborate in real time with clients and third parties, and map internal practices to industry frameworks such as HIPAA, PCI, and FTC Safeguards. Its platform not only reduces the administrative burden of ongoing assessments but also provides the structure needed to move from one-time reviews to ongoing program management.

“MSPs are increasingly being asked to manage risk as much as they manage technology,” said Zane Conkle, CEO of Cytracom. “This shift creates both a challenge and an opportunity. With the acquisition of Tentacle, we’re giving our partners the platform they need to step into this evolving role with confidence—helping clients navigate compliance, track progress over time, and build programs that stand up to external scrutiny, while also enabling MSPs to clearly demonstrate the ongoing value of their services.”

The rising demand for compliance-focused services is one of the most urgent trends in the MSP channel. SMB clients now face requirements driven by regulatory frameworks, industry-specific mandates, and cyber insurance audits. Tentacle’s ability to organize and share assessment data, manage third-party relationships, and ensure audit readiness positions it as a key component of Cytracom’s vision to simplify and scale SRM and GRC management for the channel.

“This is another step forward in building a complete platform that empowers MSPs to connect the modern workforce—securely, reliably, and within the evolving frameworks of GRC,” said John Tippett, Chief Commercial Officer. “Whether it’s unified communications, secure access, or risk management, our focus remains on making these capabilities accessible, intuitive, and impactful for the partners who deliver them every day.”

By integrating Tentacle into its broader infrastructure software platform, Cytracom continues to deepen its investment in the tools MSPs need to succeed in a risk- and compliance-driven world.

“We’ve been investing heavily in Telivy as a platform for recurring cybersecurity assessments and compliance workflows,” added Rob McDonald, Chief Product Officer at Cytracom. “Bringing in Tentacle’s proven technology allows us to combine their robust architecture with our existing development strategy, resulting in a dramatic acceleration of what we can bring to market. It significantly advances our mission to give MSPs scalable, differentiated tools for security and compliance.”

With solutions spanning VoIP, SASE, and SRM, Cytracom continues to equip partners to deliver critical infrastructure that is secure, scalable, and compliant—all from a single, unified platform built exclusively for the MSP channel.

About Cytracom

Cytracom, a Sverica Capital Management portfolio company, provides critical infrastructure technologies for businesses, delivering cloud-based unified communications and secure networking solutions tailored for managed service providers (MSPs) and small to medium-sized businesses (SMBs). By simplifying complex technologies, Cytracom ensures that businesses remain connected, secure, and resilient in an ever-evolving digital landscape. Our solutions, including SRM, GRC, UCaaS, and SASE platforms, are designed to empower businesses with the essential technologies they need to thrive. Headquartered in McKinney, Texas, Cytracom supports partners and customers across North America. To learn more, visit cytracom.com.

Media Contact: Dana Liedholm | [email protected]

SOURCE Cytracom

New capital fuels Canary’s global growth and reinforces Canary as the category leader in AI-powered guest-facing hotel technology.

SAN FRANCISCO, June 12, 2025 — Canary Technologies, the award-winning global leader in hotel guest management technology, announced today it has closed an $80 million Series D round of funding to accelerate the company’s global expansion as a leader in hospitality AI. Brighton Park Capital led the round, with participation from existing investors: Insight Partners, F-Prime Capital, Thayer Ventures, Y-Combinator and Commerce Ventures. This latest investment brings Canary’s valuation to approximately $600 million dollars.

This fundraise comes on the heels of a $50M Series C raise announced 12 months ago and caps off an impressive year of growth marked by major partnerships with Best Western, Aimbridge Hospitality, Marriott, Wyndham, TUI Hotels & Resorts, and others. Additionally, Canary unveiled the launch of new cutting-edge AI products, including AI Voice and Webchat. As global demand for AI-powered guest engagement solutions continues to rise, Canary will use the funding to accelerate its rapid expansion.

“The hospitality industry is entering a new era powered by AI, and we’re proud to be at the forefront of that transformation,” said Harman Singh Narula, CEO and Co-founder of Canary. “Through intelligent, enterprise-grade solutions, we’re helping hotels run smarter, deliver faster service and create more personalized guest experiences at scale. This latest investment reflects both the extraordinary dedication of the team—whose work is redefining what’s possible—and the growing impact Canary is making across the industry. We’re energized by the strong demand and excited to expand our partnerships with many of the world’s leading hoteliers.”

The announcement builds on Canary’s accelerating growth and influence across the hospitality sector. Today, the company supports more than 20,000 hotels in over 100 countries and serves as the enterprise partner of choice for leading global brands, including Marriott, Wyndham, Best Western and many others. Canary has earned consistent recognition from industry experts—named the #1 Guest Experience Platform in consecutive years by HotelTechReport, and recognized by Deloitte, Fast Company and more.

“This milestone reflects our team’s continued commitment to building solutions that elevate the industry,” said SJ Sawhney, President and Co-Founder of Canary Technologies. “Our AI solutions are crafted in close partnership with customers, purpose-built for hospitality, and deeply inspired by hoteliers’ day-to-day workflows. When our hotel partners dream of better service, smarter operations, or more delightful guest experiences, our team works hard to turn those dreams into reality with precision, scale and purpose.”

“Canary’s scale and growth within the travel and hospitality sector are truly unprecedented,” said Kevin Magan, Partner at Brighton Park Capital. “We’re thrilled to partner with Harman, SJ, and the entire team as they accelerate their momentum and solidify their position as a category leader. Their dedication to delivering enterprise-grade, high-impact solutions for hoteliers positions them for long-term success and sustained global leadership.”

About Canary Technologies 
Founded in 2018 by lifelong friends and hospitality experts Harman Singh Narula and SJ Sawhney, Canary Technologies was born out of a shared vision: to create intuitive, guest-centric technology that redefines the hospitality experience. Today, Canary serves properties of all sizes—from independent boutiques to global hotel brands—delivering a unified platform that modernizes hotel operations and transforms the guest journey, from pre-booking to checkout. For more information, visit http://canarytechnologies.com.

About Brighton Park Capital
Brighton Park Capital is a New York-based investment firm focused on entrepreneur-led, growth-stage software, healthcare and tech-enabled services companies. The firm invests in companies that provide highly innovative solutions in partnership with great management teams. Brighton Park brings purpose-built, value-add capabilities that match the unique requirements of each of its companies. For more information about Brighton Park Capital, please visit www.bpc.com.

SOURCE Canary Technologies

NEW YORK, June 12, 2025 — Today, Antimetal announced a $20 million Series A led by Sound Ventures to fix the modern stack’s most expensive problem: complexity.

Alongside the raise, Antimetal unveiled the beta of its flagship platform designed to automate infrastructure management so engineers can spend time where it matters: building, not maintaining.

“Writing code is no longer the hard part,” said Shreyas Iyer, Antimetal CTO. “Everything that happens after you write it—provisioning, deploying, scaling, debugging, optimizing, securing—is where teams are now getting stuck.”

“Even the best infrastructure teams at trillion-dollar companies are trapped in this cycle,” Matthew Parkhurst, CEO adds. “More dashboards, more alerts, more tools. It’s not a headcount problem. It’s a complexity problem. And throwing more people at it rarely helps.”

Antimetal offers a different path. Rather than imposing rigid frameworks, the platform learns and adapts to each team’s specific patterns and behaviors. It pulls data from every surface area of a team’s infrastructure stack, and develops an understanding of how their systems typically fail, how engineers respond to those, and what business outcomes matter most to the organization.

Over time, it internalizes this behavioral knowledge and gradually automates parts of a team’s workflow. In the process, it takes fragmented institutional knowledge that typically lives only in senior engineers’ heads and encodes it into a system that is usable by the entire team.

The result: less maintenance, fewer incidents, and more time to build.

Antimetal is now available in early access, with a wider general release planned for later in the year.

Joining Sound Ventures is an impressive list of venture capital firms and private investors. These include Buckley Ventures, Nat Friedman, Daniel Gross, Perplexity founder Aravind Srinivas, Naval Srinivasan, Ben Uretsky, the founder of Digital Ocean, Aaron Levie, founder of Box, and Arash Ferdowsi, founder of Dropbox, and others.

The Future of Infrastructure is Invisible: learn more here.

SOURCE Antimetal

New funding led by SignalFire will fuel surging enterprise demand for Customer Trust Automation solutions, with continued momentum for Sue – the AI Agent for B2B security review automation – and the acceleration of Phil, the industry’s first AI Agent for RFP automation.

SAN FRANCISCO, June 12, 2025 — Conveyor, the market leader in AI Agents for B2B customer trust workflows, including security reviews and RFPs, today announced a $20 million Series B funding round. SignalFire led the raise, with participation from Oregon Venture Fund and Cervin Ventures.

Concurrent with fundraising, enterprise software veteran Chris Farinacci (former COO of Asana, former CMO of Google Cloud) will join as an independent board member.

This investment reinforces Conveyor’s leadership in the emerging Customer Trust Automation category and highlights a vision for an AI-driven future at the intersection of compliance and sales powered by high-context, domain-expert agents. With this round, the company’s total funding reaches $40 million.

“SignalFire’s investment validates our AI-first vision for transforming customer trust,” said Chas Ballew, CEO of Conveyor. “We’re excited to accelerate our mission of fully automating complex end-to-end workflows and removing trust bottlenecks that slow down enterprise sales. With SignalFire’s support, we’re laying the foundation for a future driven by AI-to-AI interactions.”

Enterprise sales processes are routinely delayed by exhaustive security reviews. According to Conveyor’s 2024 State of Security Review, on average, reviews take 3.1 weeks to complete—contributing to deal delays for over half (52%) of sales teams. Further, just 13% of information security end users find their current process efficient. In response, a growing number of teams are turning to AI: with 31% of companies already implementing AI in their go-to-market efforts and another 24% planning to adopt within the next year.

Conveyor is riding this enterprise demand with over 1 million questions answered by ConveyorAI, more than 800,000 Trust Center interactions, and a 3x growth rate. By accelerating security reviews and RFPs, organizations are transforming compliance into a competitive revenue advantage. Unlike legacy solutions that rely on stale content libraries, low accuracy AI, and basic Trust Center automation—Conveyor’s approach builds a living, AI-managed knowledge graph of secure data. These AI Agents are specifically built to handle complex work. They are accurate, know the business’s unique context, and can perform multiple steps of end-to-end work autonomously across different tools, even as the organization evolves.

Faster Deals, Fewer Bottlenecks, and More Productivity with a Trusted AI Lineup
Sue, Conveyor’s breakthrough AI Agent, is the industry’s first end-to-end Agent to automate customer security reviews. Sue helps customers self-serve a vendor’s sensitive documents and security information using an AI-driven Trust Center, can answer security questionnaires at 95-97% accuracy without human intervention, and autonomously drives the review turnaround process down by 80%. She operates like a living AI-powered source of approved company information, eliminating some of the most tedious and time-consuming tasks in enterprise sales.

Building on Sue’s success, Conveyor has now introduced Phil, the industry’s first AI Agent dedicated to RFP automation. Phil autonomously researches RFP requirements and drafts proposal responses, helping organizations win more deals faster with less effort. Together, Sue and Phil form a powerful AI-driven pair to offload the most labor-intensive elements of customer trust workflows.

Developing truly autonomous agents that operate within enterprise environments isn’t just a technical challenge—it requires deep integration with complex processes, rigorous accuracy standards, and the trust of risk-sensitive stakeholders. Most AI tools falter when faced with the scale, nuance, and security requirements of enterprise organizations. Conveyor has already overcome these hurdles. By deploying Sue and demonstrating measurable outcomes in some of the largest tech companies in the world, Conveyor has proven that AI agents can be not only helpful, but fully dependable and enterprise-ready. This success validates Conveyor’s unique position as a pioneer in applying agentic AI to the real-world complexities of B2B customer trust.

“Conveyor is redefining agentic automation in the enterprise.” said Tony Pezzullo, Principal at SignalFire. “Conveyor’s work with large, sophisticated technology organizations like Workday and Atlassian stood out from the legions of SMB-focused & ‘prosumer’ tools. Their vision enables the first platform for agent-to-agent communication in customer trust workflows; building the canonical interface for RFPs, security questionnaires, and eventually all high-fidelity customer-facing knowledge base queries.”

Building an AI-Driven Future with Customer Trust at the Center
In addition to expanding Sue and Phil’s availability, Conveyor will use funding to scale AI research and engineering teams, expand go-to-market initiatives, and advance a long-term vision of enabling AI-to-AI trust exchange—as the trust layer for future interactions between buyer and seller AIs.

According to Zendesk’s Senior Security Manager of Trust & Assurance, Bogdan Gagea, “Since adopting Conveyor, we’ve reduced processing time by 20%, saved about 120 hours per month, and improved on-time deliverables. This support helps our go-to-market teams close more deals and renewals, making Conveyor essential for transforming our security function from a cost center into a revenue driver.”

“We’re especially excited about Conveyor’s ambition: leading the Customer Trust category and delivering AI Agents that live up to automation expectations with Enterprise capabilities at the core,” says Chris Farinacci.

Trusted by more than 480 customers, including top-tier enterprise customers like Atlassian, Zendesk, and Qualtrics, Conveyor has already proven this technology accelerates trust building and unlocks faster revenue growth for high-profile organizations.

To learn more about Conveyor, please visit https://www.conveyor.com.

About Conveyor
Conveyor is the leading generative AI-powered platform that automates and scales the most tedious parts of the sales process: customer security reviews and RFPs. Trusted by the world’s top SaaS companies, Conveyor helps vendors build trust with customers while reducing the time spent on the mind-numbing task of sharing security information, answering security questionnaires, and responding to RFPs by over 90%.

SOURCE CONVEYOR

• Commons Clinic is redefining specialty care with a next-generation model for integrated, physician-led prevention and intervention that meets people where they are
• Its new Wholebody program provides comprehensive diagnostics and direct specialist treatments that unite musculoskeletal, cardiovascular, women’s health, metabolic, orthopedic, GI, chronic pain, and preventive oncology care into one seamless system

LOS ANGELES, June 12, 2025 — Commons Clinic today announced a $26 million Series B financing, bringing its total funding to over $60 million. The round was led by RA Capital, with participation from Floating Point, SteelSky Ventures, Time BioVentures, Courtside Ventures, and Commons Clinic physicians. This funding supports the launch of Wholebody by Commons Clinic, a multi-specialty suite connecting all of the organization’s advanced preventative care offerings. Through early detection, tailored prevention, and accountable intervention, Wholebody furthers Common Clinic’s mission to reinvent specialty care.

Wholebody puts Commons Clinic’s team of renowned specialists at the center of early detection and prevention. Its five specialty programs harness advanced diagnostic technologies to thoroughly evaluate essential health indicators like cardiometabolic wellness, musculoskeletal conditions, women’s health, weight management, hormonal balance, gastrointestinal health, chronic pain, and preventive oncology. Each patient program includes up to three specialty consults via Commons Clinic’s national expert network and offers priority placement into its vetted “FastPass” network of primary care partners, ensuring patients experience accelerated, contiguous, and highly accountable care.

Whether identifying the BRCA gene in women prompting prophylactic mastectomy in Commons’ surgery centers, detecting unacceptable coronary plaque levels requiring a PCI procedure, or discovering early-stage cancer markers via the Galeri test and facilitating rapid connection to its oncology expert network, Commons Clinic puts patients on immediate, actionable pathways to specialized care.

“Specialty healthcare too often begins after prevention fails. Patients lack timely access to specialized clinical expertise, leaving conditions to worsen over time before they receive treatment,” said Nick Aubin, co-founder and CEO of Commons Clinic. “Equipped with the industry’s most advanced technologies, we are able to quantify health risk, identify specific conditions, and quickly treat issues across the entire body.”

Inspired by institutions like the Mayo Clinic, Cleveland Clinic, Hospital for Special Surgery, and MD Anderson for their enduring legacy of advancing specialty healthcare, Commons Clinic’s physicians are some of the best minds in specialty medicine. Working at the heart of care delivery and innovation, their efforts are setting a new standard for high-value specialty services while reducing costs. Commons Clinic is expanding its physician-led approach across multiple high-impact specialty domains through the launch of its Wholebody program.

“At Commons Clinic, we’ve built our foundation as a musculoskeletal center-of-excellence that combines advanced surgical treatments with thoughtful conservative care,” said Ben Schwartz, MD, SVP of Care Services at Commons Clinic. “Now, we’re applying that same playbook to the entire body, extending our specialty care model into metabolic, cardiac, cancer, and women’s health. This integrated approach is exactly what people need to solve complex health challenges earlier, smarter, and with more precision.”

Commons has demonstrated success with its care philosophy centered on prevention and early intervention through its musculoskeletal care program, which prevents premature surgeries and accelerates the frontier of advanced,  high-yield surgical techniques and technologies. During the past year alone, Commons’ Dr. Andrew Wassef performed the first ever Mako robotic revision hip replacement, Dr. Hyun Bae published definitive research on the positive efficacy of allogeneic mesenchymal precursor cells for treatment of chronic low back pain, and Dr. Prem Ramkumar was named Associate Editor at the prestigious Journal of Bone & Joint Surgery.

“What sets Commons Clinic apart is its focus on delivering world-class interventional specialty care seamlessly through a vertically integrated model,” said John Loser, Managing Director at Floating Point. “Through its deep expertise in complex ambulatory surgical care and extraordinary concentration of top-tier specialty talent, Commons Clinic is reimagining the future of specialty care and building the Cleveland Clinic of tomorrow.”

Board-certified cardiologist Dr. Jenica Ortega will lead the Wholebody program, with a specific focus on building its cardiac, metabolic, bariatric, and women’s health service lines. Additionally, Brad Hively, the former CEO of The Oncology Institute, recently joined Commons’ board to leverage his 25 years of healthcare experience to advise on specialty value-based care strategy & expansion.

For additional details on Wholebody by Commons Clinic, visit commonsclinic.com/wholebody.

About Commons Clinic
Commons Clinic is pioneering an integrated, specialty-led healthcare platform that seamlessly combines preventive diagnostics with definitive, specialist-driven interventions. Spanning musculoskeletal, cardiovascular, women’s health, metabolic, chronic pain management, preventive oncology, and more. Commons Clinic unifies advanced diagnostics, personalized care pathways, and interventional procedures in a single accountable system. Its vertically integrated model ensures timely decision-making, clearer care navigation, and superior clinical outcomes. For more information, visit commonsclinic.com.

Media Contact:
[email protected]

SOURCE Commons Clinic